Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s biggest contract chipmaker, is likely to secure orders from Apple Inc to produce next-generation processors “starting as early as the second quarter of 2013,” Credit Suisse said last week.
The projected timeframe would come “earlier than expected,” Manish Nigam, head of the brokerage’s non-Japan Asia technology research division, said in note to clients on Friday, citing their recent checks with several equipment suppliers and other companies in Japan, Taiwan and China.
Previously, Credit Suisse said it expected Apple would seek a second source for its chips other than Samsung Electronics Co by either late next year or early 2014.
Nigam said their checks also suggested Apple might start chip production at TSMC by using the Taiwanese firm’s 28-nanometer (nm) technology, rather than its prior views on the 20nm node.
“If our checks are correct, the market would take this move as a surprise,” Nigam wrote in the note, although he said it was still hard to determine which product is going to be manufactured at TSMC.
Nevertheless, the brokerage said any new product would be a net addition to demand and therefore it was increasingly confident about the prospects for TSMC and Advanced Semiconductor Manufacturing Co (ASE, 日月光半導體), which is expected to package the chips, in the belief that the two companies will be ramping up capacity for a sizeable new customer starting some time in the first quarter of next year.
The brokerage on Friday upgraded shares of TSMC to “outperform” from “neutral,” and raised its target price from NT$95 to NT$109.
Shares in TSMC ended at NT$98.1 in Taipei trading on Friday, up 1.55 percent from the previous session, while ASE’s closed 0.2 percent up at NT$24.75, down 4.44 percent so far this year, according to data from the Taiwan Stock Exchange.
Taiwan and China are to build more new high-volume semiconductor fabrication plants this year and next year than any other country, together contributing more than half of all new fabs in the world by constructing eight each, SEMI said in a quarterly report yesterday. Global chipmakers are to start building 19 new high-volume fabs by the end of this year and another 10 next year to meet accelerating demand for chips from the communications, computing, healthcare, online services and automotive sectors, SEMI, an association that represents the global semiconductor sector, said in its quarterly report. “Equipment spending for these 29 fabs is
Major PC vendors expect a shortage of key components to last another 12 months until the second quarter of next year, when PC demand wanes after two years of robust expansion, a UBS analyst said yesterday. Concern has risen among investors that PC demand could weaken as the US and European economies reopen from COVID-19 lockdowns and gradually return to in-person business activities. At the annual Taiwan Conference that began on Monday, UBS analysts said they had similar discussions with companies in PC supply chains, and the feedback from major PC vendors indicated that demand remained quite strong on the back of
QUICK CHANGE: After a prolonged drought, the Water Resources Agency said it is preparing for potential floods from intense rainfall this week The Ministry of Economic Affairs yesterday announced that it was easing water restrictions in several regions, thanks to rainfall over the past few days. The water supply alert level has been downgraded from “orange” to “yellow” for Taoyuan and Hsinchu and Miaoli counties, and from “orange” to “green” for Tainan and Chiayi County, the ministry said. Only Taichung remains under “orange” alert, with round-the-clock decreased water pressure, it said. A combination of water management measures and considerable plum rains and tropical showers has seen reservoirs significantly replenished across the nation, Minister of Economic Affairs Wang Mei-hua (王美花) said. Just weeks ago water levels
OPPORTUNITY: The company aims to sell its product soon, as enterovirus vaccines are not available anywhere but China, where firms are only marketing their vaccines locally Medigen Vaccine Biologics Corp’s (高端疫苗) phase 3 clinical trials for an enterovirus 71 (EV71) vaccine completed the multi-regional, multi-central data “unblinding” yesterday, with the results, including safety, immunogenicity and efficacy, meeting its expectations. The company would compile a final analysis report as soon as possible, and apply for the new drug certificate from domestic and foreign drug authorities in the third quarter, Medigen said in a Taiwan Stock Exchange filing yesterday. Its phase 3 trials were conducted in Taiwan and Vietnam with 3,049 participants ranging from two months old to six years old, Medigen said. The company enrolled its first participant for
RSS